BBC Holdings — Virtus LifeSci Biotech Clinical Trials ETF
Data updated: 2026-09-29
BBC holds 132 securities. The top 10 make up 14.3% of net assets, led by Dreyfus Government Cash Manage (3.48%) and First Tracks Biotherapeutics, Inc. Ord Shs (1.67%). Health Care (96.6%) and Funds & ETFs (3.4%) are the largest sectors, and 86.7% of the portfolio is in United States. No debt holdings are reported.
Holdings cover 103.32% of net asset value (99.79% of total assets; remainder is cash and receivables). As of July 31, 2026 · N-PORT.
BBC Portfolio Holdings
132 holdings of Virtus LifeSci Biotech Clinical Trials ETF by percentage of net assets, from the fund's SEC N-PORT filing as of July 31, 2026. The 100 largest are listed below; the interactive table on this page lists all 132.
| Holding | Ticker | Sector | % of net assets | Value (USD) |
|---|---|---|---|---|
| Dreyfus Government Cash Manage | DGCXX | Funds & ETFs | 3.48% | $1.61M |
| First Tracks Biotherapeutics, Inc. Ord Shs | TRAX | Health Care | 1.67% | $775.98K |
| Mbx Biosciences Inc.com | MBX | Health Care | 1.24% | $577.15K |
| Ataibeckley Inc.com Shs | ATAI | Health Care | 1.23% | $569.30K |
| Monopar Therapeutics Inc.com New | MNPR | Health Care | 1.21% | $563.42K |
| Definium Therapeutics Inc.com Shs | DFTX | Health Care | 1.18% | $546.52K |
| Xencor Inc.com | XNCR | Health Care | 1.10% | $509.45K |
| Zenas Biopharma Inc.com | ZBIO | Health Care | 1.06% | $493.51K |
| Uniqure NV Shs | QURE | Health Care | 1.06% | $491.84K |
| Apogee Therapeutics Inc.com | APGE | Health Care | 1.02% | $471.86K |
| Vor Biopharma Inc.com New | VOR | Health Care | 0.99% | $457.77K |
| Regenxbio Inc.com | RGNX | Health Care | 0.97% | $452.23K |
| Lb Pharmaceuticals Inc.com Shs | LBRX | Health Care | 0.94% | $438.31K |
| Damora Therapeutics Inc.com Usd0.00001 | DMRA | Health Care | 0.93% | $433.60K |
| Amylyx Pharmaceuticals Inc.com | AMLX | Health Care | 0.93% | $432.66K |
| Dyne Therapeutics Inc.com | DYN | Health Care | 0.93% | $430.25K |
| Oruka Therapeutics Inc.com | ORKA | Health Care | 0.93% | $429.18K |
| Nurix Therapeutics Inc.com | NRIX | Health Care | 0.92% | $425.60K |
| Oric Pharmaceuticals Inc.com | ORIC | Health Care | 0.90% | $416.07K |
| Gh Research PLC Ordinary Shares | GHRS | Health Care | 0.89% | $413.08K |
| Sionna Therapeutics Inc.com | SION | Health Care | 0.88% | $407.82K |
| Dianthus Therapeutics Inc.com | DNTH | Health Care | 0.87% | $404.91K |
| Erasca Inc.com | ERAS | Health Care | 0.87% | $401.51K |
| Jade Biosciences Inc.com New | JBIO | Health Care | 0.86% | $400.15K |
| Sellas Life Sciences Group Inc.com New | SLS | Health Care | 0.86% | $397.35K |
| Palvella Therapeutics Inc.com | PVLA | Health Care | 0.86% | $397.10K |
| Relay Therapeutics Inc.com | RLAY | Health Care | 0.85% | $395.22K |
| Replimune Group Inc.com | REPL | Health Care | 0.84% | $392.01K |
| Alto Neuroscience Inc.com Shs | ANRO | Health Care | 0.84% | $391.87K |
| Adlai Nortye Ltd. Sponsored ADS | ANL | Health Care | 0.84% | $391.52K |
| Bicara Therapeutics Inc.com | BCAX | Health Care | 0.84% | $388.37K |
| Immunome Inc.com | IMNM | Health Care | 0.83% | $384.89K |
| Avalo Therapeutics Inc.com New | AVTX | Health Care | 0.83% | $384.31K |
| Meiragtx Holdings Plc.com | MGTX | Health Care | 0.82% | $382.11K |
| Ideaya Biosciences Inc.com | IDYA | Health Care | 0.82% | $380.74K |
| Spyglass Pharma Inc.com Shs | SGP | Health Care | 0.82% | $379.74K |
| Kodiak Sciences Inc.com | KOD | Health Care | 0.82% | $379.42K |
| Revolution Medicines Inc.com | RVMD | Health Care | 0.82% | $378.81K |
| Celldex Therapeutics Inc.com New | CLDX | Health Care | 0.82% | $378.32K |
| Spyre Therapeutics Inc.com New | SYRE | Health Care | 0.82% | $378.28K |
| Cullinan Therapeutics Inc.com | CGEM | Health Care | 0.81% | $374.34K |
| Lexicon Pharmaceuticals Inc.com New | LXRX | Health Care | 0.81% | $373.95K |
| Xenon Pharmaceuticals Inc.com | XENE | Health Care | 0.81% | $373.89K |
| Kymera Therapeutics Inc.com | KYMR | Health Care | 0.80% | $372.76K |
| Biohaven Ltd.com | BHVN | Health Care | 0.80% | $371.98K |
| Cg Oncology Inc.com | CGON | Health Care | 0.80% | $371.47K |
| Nektar Therapeutics.com New | NKTR | Health Care | 0.80% | $369.89K |
| Enliven Therapeutics Inc.com | ELVN | Health Care | 0.80% | $369.31K |
| Arcus Biosciences Inc.com | RCUS | Health Care | 0.79% | $368.16K |
| Tyra Biosciences Inc.com | TYRA | Health Care | 0.79% | $367.13K |
| Rezolute Inc.com New | RZLT | Health Care | 0.79% | $366.77K |
| Cogent Biosciences Inc.com | COGT | Health Care | 0.79% | $365.55K |
| Alumis Inc.com | ALMS | Health Care | 0.78% | $363.58K |
| Candel Therapeutics Inc.com | CADL | Health Care | 0.78% | $363.46K |
| Sana Biotechnology Inc.com | SANA | Health Care | 0.78% | $363.00K |
| Achieve Life Sciences Inc.com | ACHV | Health Care | 0.78% | $361.50K |
| Olema Pharmaceuticals Inc.com | OLMA | Health Care | 0.78% | $360.56K |
| Viridian Therapeutics Inc.com | VRDN | Health Care | 0.78% | $359.67K |
| Praxis Precision Medicines Inc.com New | PRAX | Health Care | 0.77% | $358.93K |
| 4d Molecular Therapeutics Inc.com | FDMT | Health Care | 0.77% | $358.33K |
| Immunovant Inc.com | IMVT | Health Care | 0.77% | $357.04K |
| Belite Bio, Inc. Sponsored ADS | BLTE | Health Care | 0.77% | $356.87K |
| Vaxcyte Inc.com | PCVX | Health Care | 0.76% | $354.17K |
| Disc Medicine Inc.com | IRON | Health Care | 0.76% | $351.97K |
| Rocket Pharmaceuticals Inc.com | RCKT | Health Care | 0.76% | $351.50K |
| Generate Biomedicines Inc.com Shs | GENB | Health Care | 0.76% | $351.48K |
| Neurogene Inc.com | NGNE | Health Care | 0.76% | $351.30K |
| Solid Biosciences Inc.com New | SLDB | Health Care | 0.76% | $350.86K |
| Maze Therapeutics Inc.com | MAZE | Health Care | 0.75% | $347.91K |
| Structure Therapeutics, Inc. Sponsored ADS | GPCR | Health Care | 0.75% | $347.81K |
| Janux Therapeutics Inc.com | JANX | Health Care | 0.75% | $347.74K |
| Corvus Pharmaceuticals Inc.com | CRVS | Health Care | 0.74% | $345.48K |
| Design Therapeutics Inc.com | DSGN | Health Care | 0.74% | $345.10K |
| Viking Therapeutics Inc.com | VKTX | Health Care | 0.74% | $343.14K |
| Edgewise Therapeutics Inc.com | EWTX | Health Care | 0.74% | $342.99K |
| Assembly Biosciences Inc.com New | ASMB | Health Care | 0.73% | $339.91K |
| Aura Biosciences Inc.com | AURA | Health Care | 0.73% | $339.91K |
| Veradermics, Inc. Common Stock | MANE | Health Care | 0.73% | $339.68K |
| Abcellera Biologics Inc.com | ABCL | Health Care | 0.73% | $338.69K |
| Altimmune Inc.com New | ALT | Health Care | 0.73% | $338.20K |
| Annexon Inc.com | ANNX | Health Care | 0.72% | $336.21K |
| Mineralys Therapeutics Inc.com | MLYS | Health Care | 0.72% | $335.82K |
| Scholar Rock Holding Corp.com | SRRK | Health Care | 0.72% | $332.72K |
| Rapport Therapeutics Inc.com | RAPP | Health Care | 0.71% | $331.69K |
| Pharvaris Nv.com | PHVS | Health Care | 0.71% | $330.05K |
| Arvinas Inc.com | ARVN | Health Care | 0.71% | $329.26K |
| Prime Medicine Inc.com | PRME | Health Care | 0.70% | $327.05K |
| Bridgebio Oncology Therapeutics Inc.com New | BBOT | Health Care | 0.70% | $324.47K |
| Climb Bio Inc.com | CLYM | Health Care | 0.70% | $323.33K |
| Savara Inc.com | SVRA | Health Care | 0.70% | $322.63K |
| Upstream Bio Inc.com | UPB | Health Care | 0.69% | $321.51K |
| Cytomx Therapeutics Inc.com | CTMX | Health Care | 0.69% | $320.10K |
| Taysha Gene Therapies Inc.com Shs | TSHA | Health Care | 0.69% | $318.98K |
| Oculis Holding AG Ordinary Shares | OCS | Health Care | 0.68% | $316.99K |
| Arbutus Biopharma Corp.com | ABUS | Health Care | 0.68% | $316.66K |
| Aktis Oncology Inc.com | AKTS | Health Care | 0.67% | $312.80K |
| Vir Biotechnology Inc.com | VIR | Health Care | 0.67% | $312.62K |
| Allogene Therapeutics Inc.com | ALLO | Health Care | 0.66% | $307.54K |
| Moonlake Immunotherapeutics Class A Ord | MLTX | Health Care | 0.66% | $306.66K |
| Immix Biopharma Inc.com | IMMX | Health Care | 0.66% | $306.03K |
BBC Sector Allocation
Virtus LifeSci Biotech Clinical Trials ETF holdings grouped by sector, by share of the portfolio's market value.
| Sector | Weight | Holdings |
|---|---|---|
| Health Care | 96.6% | 131 |
| Funds & ETFs | 3.4% | 1 |
BBC Country Allocation
Where Virtus LifeSci Biotech Clinical Trials ETF's holdings are domiciled, by percentage of net assets (largest 9).
| Country | % of net assets |
|---|---|
| United States | 86.7% |
| Cayman Islands | 5.3% |
| Canada | 3.4% |
| Netherlands | 3.0% |
| Ireland | 1.6% |
| United Kingdom | 1.3% |
| British Virgin Islands | 0.8% |
| Switzerland | 0.7% |
| Singapore | 0.6% |
BBC Portfolio Allocation
Asset-class allocation of Virtus LifeSci Biotech Clinical Trials ETF by percentage of net assets, from the latest SEC N-PORT filing.
| Asset class | Allocation |
|---|---|
| Equity | 99.8% |
| Cash & Equivalents | 3.5% |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.